lamivudine and zidovudine
Drug Details
- Generic Name
- lamivudine and zidovudine
- Brand Names
- COMBIVIR, LAMIVUDINE AND ZIDOVUDINE
- Application Number
- NDA020857
- Sponsor
- ViiV Healthcare Company
- NDC Codes
- 2
- Dosage Forms
- TABLET, FILM COATED
- Routes
- ORAL
- Active Ingredients
- LAMIVUDINE, ZIDOVUDINE
Indications and Usage
1 INDICATIONS AND USAGE COMBIVIR, a combination of 2 nucleoside analogues, is indicated in combination with other antiretrovirals for the treatment of human immunodeficiency virus type 1 (HIV‑1) infection. COMBIVIR, a combination of 2 nucleoside analogue reverse transcriptase inhibitors, is indicated in combination with other antiretroviral agents for the treatment of HIV‑1 infection. ( 1 )